Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human monoclonal antibodies to ganglioside GD2

Human monoclonal antibodies to ganglioside GD2

US Patent 11760809 · Granted Sep 19, 2023

Estimated economic value: $97,340,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for delivering nitric oxide2024
Systems and methods for ambulatory generation of nitric oxide2024
Systems and methods for generating nitric oxide2023
Systems and methods for preventing and treating infections with nitric oxide2023
Human antibodies to Tn antigen2023
Human antibodies to Tn antigen2023
Systems and methods for nitric oxide generation with humidity control2023
Systems and methods for ambulatory generation of nitric oxide2023
Systems and methods for ambulatory generation of nitric oxide2022
Electrodes for nitric oxide generation2022
Systems and methods for generating nitric oxide2022
Electrodes for nitric oxide generation2021